Skip to main content
. 2022 May 27;12:769576. doi: 10.3389/fonc.2022.769576

Table 1.

Overall demographics and preoperative clinical manifestations.

Variables Overall (n = 98) Craniopharyngioma (n = 48) RCC (n = 19) Pituitary adenoma (n = 16) Germinoma (n = 8) Chordoma (n = 3) LCH (n = 2) Others (n = 2) P-value
Median age (yrs, range) 12 (4-18) 12 (4-18) 10 (6-17) 14 (10-17) 12 (9-15) 7 (6-10) 10 (10-11) 11 (6-16) .056
Sex (%) .415
Male 52 (53) 30 (62) 9 (47) 6 (38) 2 (25) 2 (67) 1 (50) 2 (100)
Female 46 (47) 18 (38) 10 (53) 10 (62) 6 (75) 1 (33) 1 (50)
Median follow-up duration (months) 59 58 41 68 74 100 50 93 .633
Hydrocephalus* (%) 11 (11) 10 (21) 1 (9) .041
Visual status† (%) .164
Normal 45 (46) 19 (40) 8 (42) 9 (56) 5 (62) 2 (67) 1 (50) 1 (50)
Disturbed 53 (54) 29 (60) 11 (58) 7 (44) 3 (38) 1 (33) 1 (50) 1 (50)
Anterior pituitary function‡ (%) .023
Normal 29 (30) 7 (15) 7 (36) 10 (62) 3 (38) 2 (67)
Partial deficiency 28 (29) 15 (31) 6 (32) 3 (38) 1 (33) 2 (100) 1 (50)
Panhypopituitarism 41 (41) 26 (54) 6 (32) 6 (38) 2 (24) 1 (50)
Diabetes insipidus§ (%) 32 (33) 20 (42) 5 (26) 7 (88) .153

*Includes headache, seizure, altered consciousness.

†Includes blurred vision, visual field defect.

‡Includes amenorrhea, galactorrhea, sudden weight gain, short stature, morphologic change.

§Includes polydipsia, polyuria.

RCC, Rathke's cleft cyst; LCH, Langerhans cell histiocytosis.